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Abstract
Background: The objective was to define murine histologic alterations resembling asthma in a
BALB/c OVA model and to suggest grading criteria. Identified were six salient histologic findings in
lungs with putative allergic inflammation: 1) bronchoarterial space inflammation; 2) peri-venular
inflammation; 3) inflammation about amuscular blood vessels; 4) inter-alveolar space inflammation,
not about capillaries; 5) pleural inflammation; and 6) eosinophils within the inflammatory
aggregates. An initial study comprised six groups of twelve mice each: 1) stressed, control; 2)
stressed, sensitized; 3) stressed, challenged; 4) not physically stressed, control; 5) not physically
stressed, sensitized; 6) not physically stressed, challenged. A second study comprised four
experimental groups of twenty mice each: 1) stressed, control; 2) stressed, challenged; 3) not
physically stressed, control; 4) not physically stressed, challenged. A third study evaluated two
grading criteria, 1) the proportion of non-tracheal respiratory passages with inflammatory
aggregates and 2) mitoses in the largest two non-tracheal respiratory passages, in five groups of five
mice each, evaluated at different times after the last exposure.
Results: The first study suggested the six histological findings might reliably indicate the presence
of alterations resembling asthma: whereas 82.4% of mice with a complete response had detectable
interleukin (IL)-5, only 3.8% of mice without one did; whereas 77.8% of mice with a complete
response were challenged mice, only 6.7% of mice without complete responses were. The second
study revealed that the six histological findings provided a definition that was 97.4% sensitive and
100% specific. The third study found that the odds of a bronchial passage's having inflammation
declined 1) when mitoses were present (OR = 0.73, 0.60 - 0.90), and 2) with one day increased
time (OR = 0.75, 0.65 - 0.86).
Conclusion: A definition of murine histologic alterations resembling asthma in the BALB/c OVA
mouse was developed and validated. The definition will be of use in experiments involving this
model to ensure that all mice said to have undergone an asthmatic attack did indeed reveal allergic
pulmonary inflammation. Proposed grading criteria should be further evaluated with additional
studies using physiologic measures of attack severity and increased airway resistance.
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Background
Asthma currently afflicts about 300,000,000 persons and
was estimated in 2005 to have killed 255,000 [1].
Although some have considered murine models to be
inappropriate as means of understanding human asthma
[2], most feel the mouse model is vital, especially with
respect to the understanding of the early response to anti-
gens and the mediators of allergic asthma [3,4]. The
BALB/c OVA mouse model is one of the most commonly
used [5]. Although a general understanding of the histo-
logical findings of the BALB/c OVA mouse has been gen-
erated by the publication of different studies [3], a
systematic approach to the most important aberrations to
garner a readily identifiable histological definition has not
been performed. Such a definition would be of utility as a
safeguard when performing studies using the BALB/c OVA
mouse because it would ensure that all individual animals
submitted for study experienced histologic changes
resembling asthma. Moreover, such a definition would be
of use because therapeutic manipulations that abolish the
findings would then be designated as successfully obliter-
ating the attack. Posited was a specific pattern of histolog-
ical findings, derivable from generally accepted
observations of BALB/c OVA mice. Six salient findings
were identified in lung sections with putative allergic
inflammation: 1) bronchoarterial space inflammation; 2)
peri-venular inflammation; 3) inflammation about amus-
cular blood vessels; 4) inter-alveolar space inflammation,
not about capillaries; 5) pleural inflammation; and 6)
eosinophils within the inflammatory aggregates. An ini-
tial study comprised of six experimental groups of twelve
mice each, randomly assigned: 1) stressed, control; 2)
stressed, sensitized; 3) stressed, challenged; 4) not physi-
cally stressed, control; 5) not physically stressed, sensi-
tized; 6) not physically stressed, challenged. A second
study comprised of four experimental groups of twenty
mice each, randomly assigned: 1) stressed, control; 2)
stressed, challenged; 3) not physically stressed, control; 4)
not physically stressed, challenged. A third study evalu-
ated two grading criteria, 1) the proportion of non-tra-
cheal respiratory passages with inflammatory aggregates
and 2) the presence or absence of mitoses in the largest
two non-tracheal respiratory passages, in five experimen-
tal groups of five mice each, assigned to different times
after the last exposure.
Results
Definition of murine histologic alterations resembling 
asthma
Based on evaluation of prior literature [6-26] and detailed
examination of associated photomicrographs, six histo-
logical features were deemed most important and most
reliably assessed: 1) inflammation of bronchoarterial
spaces; 2) perivenular inflammation; 3) inflammation
about amuscular blood vessels; 4) inflammation in inter-
alveolar spaces, not surrounding capillaries; 5) pleural
inflammation; and 6) eosinophils within the inflamma-
tory aggregates. Each of the features is shown in Figure 1;
corresponding photographs of normal mouse lungs are
shown in Figure 2. For the first study set, mice lungs were
assessed for each characteristic at 200×, before the mice
were divided into complete response (all six changes),
incomplete response (1 to 6 changes), and no response (0
changes). The presence of all six findings indicated that
inflammatory infiltrates were distributed throughout the
lung; further subclassification of location was impossible
for routine assessments because, for any particular sec-
tion, the size of the respiratory passages and pulmonary
veins and their location with respect to the trachea and
pleura depend upon the precise location of the section
within the lung and the orientation of the lung at the time
histological sections are created, matters that cannot be
controlled without great difficulty. There were 27 mice
with a complete response, 29 mice with an incomplete
response, and 16 mice with no response. Attempts to use
a continuous variable for the histologic changes (e.g., the
number of characteristics) yielded models that fit poorly;
moreover, as shown below there was excellent correlation
between allergic challenge and complete response and
good correlation between incomplete response and sensi-
tization and between no response and control. With a
Photomicrographs of mouse lungs with a complete response Figure 1
Photomicrographs of mouse lungs with a complete 
response. a. Inflammation in bronchoarterial space (hema-
toxylin and eosin, original maginification 200 ×). b. Inflama-
tion about pulmonary vein (hematoxylin and eosin, original 
maginification 200 ×); c. inflammation about amuscular blood 
vessels (hematoxylin and eosin, original maginification 200 ×); 
d. Inflammation in inter-alveolar spaces, not surrounding 
blood vessels (hematoxylin and eosin, original maginification 
200 ×); e. Pleural inflammation (hematoxylin and eosin, origi-
nal maginification 200 ×); f. Eosinophils within inflammatory 
aggregate (hematoxylin and eosin, original maginification 
1000 ×); g. Low power appearance (hematoxylin and eosin, 
original magnification 40 ×).BMC Immunology 2009, 10:58 http://www.biomedcentral.com/1471-2172/10/58
Page 3 of 11
(page number not for citation purposes)
modest degree of experience, complete responses were
distinguished in seconds at low power; photomicrographs
of a complete response at low power (fig. six-g) and a nor-
mal lung at low power (fig. seven - g) are provided. Eval-
uations for the second and third study sets began with
evaluation at 20×, always confirmed at high power for the
presence of eosinophils in the infiltrates.
Studies to establish and validate the definition of murine 
histologic alterations resembling asthma
Of the 72 mice in the first study, BAL fluid from 47 were
evaluated for detectable interleukin (IL)-4 and 43 were
assayed for detectable IL-5, and serum from 61 mice were
examined for the IgE concentration. A table [see Addi-
tional file 1- Table S1] shows that differences in propor-
tions with respect to histological groups and 1)
immunologic groups, 2) detectable IL-5, and 3) Immu-
noglobulin E (IgE), and with respect to immunologic
groups and 1) detectable IL-5 and 2) IgE could not be
explained by chance (P < 0.05 for each examination). Dif-
ferences in proportions with respect to IL-4 and 1) histo-
logical groups and 2) treatment could have been
explained by chance (P > 0.05 for each examination). Dif-
ferences in proportions with respect to Stress and 1) histo-
logical groups, 2) immunologic groups, 3) detectable IL-
4, 4) detectable IL-5, and 6) IgE could have been
explained by chance (P  > 0.05 for each examination).
Multinomial logit regression of histological groups per-
formed with forward step regression with BIC identified
only immunologic groups as being important; the top
half of figure 3 displays the results. The ratio of mice with
a complete response to mice to mice with an incomplete
response was about 45 times greater for challenged than
for immunized mice (P < 0.05); differences between con-
trol and sensitized mice might have been due to chance (P
> 0.05). The ratio of mice with no histological response to
mice to mice with an incomplete histological response
was about 7 times greater for control than for sensitized
mice (P < 0.05); differences between challenged and sen-
sitized mice might have been due to chance (P > 0.05).
Binomial logit regression of detectable IL-5 performed
with forward step regression with BIC identified immuno-
logic groups and histological groups as being important;
the bottom half of figure 3 displays the results. Adjusted
for histological group, the odds of a challenged mice hav-
ing detectable IL-5 are about 70% greater than those of a
sensitized mouse (P  < 0.05). Adjusted for histological
group, the odds of a control mouse's having detectable IL-
5 are about 30% greater than those of a sensitized mouse
(P < 0.05); both control mice who had detectable IL-5 had
complete responses. Adjusted for immunologic treatment
group, the odds of a mouse with a complete response's
having detectable IL-5 are about 70% greater than those of
a mouse with an incomplete response (P < 0.05); differ-
ences between mice with no response and mice with
incomplete responses might have been due to chance (P >
0.05). Log gamma regression of IgE concentration per-
formed with forward step regression with BIC identified
immunologic groups and histological groups as being
important; the bottom half of figure 3 displays the results.
Adjusted for histological group, the odds of a challenged
mouse's having detectable IL-5 are about 70% greater
than those of a sensitized mouse (P < 0.05). Adjusted for
histological group, control mice IgE levels are about 60%
less than are those of sensitized mice (P < 0.05); differ-
ences between challenged mice and sensitized mice might
have been due to chance (P < 0.05). Adjusted for immu-
nologic treatment group, mice with no response had
about 60% less IgE than mice with an incomplete
response (P  < 0.05); differences between mice with
incomplete responses and mice with complete responses
might have been due to chance (P > 0.05). The results
indicate that sensitization correlated with an elevation in
IgE that was not changed by allergic challenge more than
would be expected by chance, validating its utility as a
control. Taken together, the results suggest a complete
response might be a good definition of the histologic
alterations resembling asthma: whereas 82.4% of mice
with a complete response had detectable IL-5, only 3.8%
of mice without one did (OR 93.4, 95% c.i. 9.5 - 4904.8,
P  < 0.05); whereas 77.8% of mice with a complete
Photomicrographs of control mouse lungs Figure 2
Photomicrographs of control mouse lungs. a. Broncho-
arterial space without inflammation (hematoxylin and eosin, 
original maginification 200 ×). b. Pulmonary vein without 
inflammation (hematoxylin and eosin, original maginification 
200 ×); c. Amuscular blood vessels without inflammation 
(hematoxylin and eosin, original maginification 200 ×); d. 
Inter-alveolar spaces without inflammation (hematoxylin and 
eosin, original maginification 200 ×); e. Pleura lacking inflam-
mation. (hematoxylin and eosin, original maginification 200 
×); f. Small peri-bronchial inflammatory aggregate without 
eosinophils (hematoxylin and eosin, original maginification 
1000 ×); g. Low power appearance (hematoxylin and eosin, 
original magnification 40 ×).BMC Immunology 2009, 10:58 http://www.biomedcentral.com/1471-2172/10/58
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response were challenged mice, only 6.7% of mice with-
out complete responses were (OR 44.6, 9.6 - 304.7, P <
0.05).
Of the 80 mice from the second study, two mice, both
challenged and stressed, expired before the end of the
swim stress; the pair was excluded from further assess-
ment. A second table [see Additional file 2- Table S2]
shows that the different experimental protocols differenti-
ated mice with respect to the presence or absence of a
complete response protocols (P  < 0.05) and that they
failed to do so with respect to hemorrhage (P > 0.05) and
alveolar dilatation (P > 0.05). Stress did not affect the like-
lihood of a complete response; complete responses were
seen in 18 of 38 (47.4%) stressed mice and 19 of 40
(47.5%) non-stressed mice (P > 0.05). By contrast, com-
plete responses were seen in 37 of 38 (97.4%) challenged
mice and 0 of 40 (0%) control mice (P < 0.05), yielding a
sensitivity of 97.4% and a specificity of 100%.
Studies performed to propose potential grading 
parameters
For the evaluation of the semi-quantitative inflammation
grading system, all 27 complete response mice from the
first study set were used. Eighteen had evaluable IL-4
measurements; 17 had evaluable IL-5 measurements. Fig-
ure 4 displays results of univariate regressions on the
modified subjective inflammatory grading system. All
evaluated relationships could have been explained by
chance (P > 0.05 for each analysis). Goblet cell/mucin
production had the largest effect size with respect to stress,
but in the opposite direction that had been indicated by
Pastva [17] and then in a fashion explainable by chance (P
> 0.05). Proliferation and inflammation had opposed
effects explainable by chance with respect to stress and
detectable IL-4.
A third table [see Additional file 3- Table S3] displays
results of the study of the quantitative proliferation/
hypertrophy markers that evaluated 64 mice from the sec-
ond study set. Relationships of cells per 0.1 mm and
mitoses with dilatation, hemorrhage, stress and one
another were explainable by chance (P > 0.05 for each
evaluation). The median number of cells per 0.1 mm of
basement membrane was four fewer for allergic mice than
control mice (P < 0.05); the difference, too small to use for
evaluation of subgroups of challenged animals, was con-
sistent with the presence of larger cells, perhaps via induc-
tion of goblet cell metaplasia. Mitoses were seen in 65.6%
Initial study Figure 3
Initial study. Results of regression analyses performed to evaluate the relationship of the differing immunologic treatments to 
the differing histologic categories (top) and the relationship of the differing histologic findings and immunologic treatments to 
IL-5 detectability (bottom).BMC Immunology 2009, 10:58 http://www.biomedcentral.com/1471-2172/10/58
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of allergic mice and 3.1% of controls (OR = 54.9, 7.3 -
2484.5, P < 0.05).
Of 25 mice in the third study set, two lacked a complete
histological response, one at 12 and one at 24 hours. Fig-
ure 5 presents the results of evaluations of the remaining
23 mice. On the left is a scatter plot of proportions of res-
piratory passages with chronic inflammatory infiltrates
and times after exposure, with presence or absence of
mitoses differentiated by symbols. On the right are results
of step forward binomial logit regression; the odds of a
bronchial passage's having inflammation declined 1)
when mitoses were present (OR = 0.73, 0.60 - 0.90, P <
0.05), adjusted for time, and 2) with increased time (OR
with one day of increased time = 0.75, 0.65 - 0.86, P <
0.05), adjusted for mitoses.
Discussion
Histologic changes deemed important in the OVA BALB/c
mouse model in previous studies were found in the cur-
rent effort, but this study identified a set of six histological
findings that the second study set showed was 97.4% sen-
sitive and 100% specific for mice underwent an allergic
challenge. Acute stress was evaluated by multiple compar-
isons and never found to be of importance in this model.
Alveolar dilatation and hemorrhage, not being shown to
be associated with allergic challenge, stress, detectable IL-
4, detectable IL-5, epithelial cell concentration, or mitotic
activity, likely resulted from bronchoalveolar lavage
(BAL). Although the semi-quantitative grading system did
not prove successful in the first study group, quantitative
measures proved more promising: in the second study
group, challenged mice, when compared with control
mice, had a small but significant decrease in bronchial
epithelial cells per 0.1 mm basement membrane and
markedly increased odds of having mitoses in the largest
non-tracheal respiratory passage. In the third study, time
since exposure was associated with a decline in the pro-
portion of inflamed non-tracheal respiratory passages, a
decline that was increased by the presence of mitoses in
the two largest non-tracheal respiratory passages. The lat-
ter finding allows one to posit as grading parameters the
proportion of inflamed respiratory passages and mitotic
activity.
Prior studies of the BALB/c OVA mouse asthma model
that evaluated pulmonary histological changes in some
cases restricted their interest to the trachea or main bron-
Semi-quantitative inflammatory grading system Figure 4
Semi-quantitative inflammatory grading system. Results of univariate regression analyses performed to evaluate rela-
tionships between each of three predictor variables, IL-4, IL-5, and stress, and each of four outcome variables, epithelial hyper-
trophy/hyperplasia, bronchovascular inflammation, goblet cell/mucin production, and the overall inflammatory index.BMC Immunology 2009, 10:58 http://www.biomedcentral.com/1471-2172/10/58
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chus [7,27,28]. Collins [12] provided results of histologic
evaluations of 15 mice, with photographs that appear to
show a complete response for acutely sensitized mice and
an incomplete response for chronically sensitized mice.
Because immunization is known to in and of itself be
responsible in humans and cats for an anaphylaxis,
[29,30] the findings suggest that any study comparing
immunized and allergic mice carefully evaluate the histo-
logical findings in all animals to exclude those who expe-
rienced allergic pulmonary inflammation resulting from
the immunization. Four sensitized animals in this study
developed a complete histological response. The allergic
response, if it occurred, occurred at an earlier stage is sug-
gested by the absence of detectable IL-5 in three of the
mice.
When histological findings are obliterated by therapy, the
change of a histological response, and not the degree of
the response, is documented. Soluble IL-15Rα [20] and
rolipram [21] obliterate inflammation, extirpating, not
simply diminishing, the response. Antigen pulsed den-
dritic cells alter the histological appearance by eliminating
the eosinophils, which does not merely diminish the asth-
matic attack, but actually reduces the airway responsive-
ness to methylcholine beneath that observed in control
animals [22]; the latter paper is of note, as it identified as
important interalveolar and subpleural inflammatory
infiltrate. Desmet [23,24] showed diminution to an
apparent incomplete response after treatment with
nuclear factor- κB (NF-κB) and activator protein-1 decoy
oligodeoxyribonucleotides. Photographs in this paper
show peri-bronchial inflammation, the reason for the des-
ignation, in this paper, of "bronchoarterial space." Inflam-
mation is not uniformly distributed about the airways,
but shows a marked predilection for the side adjacent to
arteries and arterioles. For this reason, statements such as
"peri-bronchial and peri-vascular" [22,25] confuse unless
the latter term references pulmonary veins. However, IL-4
and IL-13 were reported to induce airway responsiveness
in the absence of inflammation [26].
de Siqueira [13] found wrinkling of the epithelium and
dilatation of the alveolar spaces, which they demarcated
as emphysematous to be of importance. Because their
mice underwent BAL, it became of interest to see if the
wrinkling and the alveolar dilatation might be unrelated
to an asthmatic challenge. Some degree of bronchial epi-
thelial wrinkling was seen in at least one airway in all
mice; because quantifying the degree of wrinkling and the
proportion of airways with wrinkling was difficult at best.
Study of mice euthanized at different times after challenge Figure 5
Study of mice euthanized at different times after challenge. Scatterplot of proportions of respiratory passages with 
inflammation and times after treatment (left). Results of regression analysis performed to evaluate the relationship of mitotic 
activity and time after treatment to the proportion of respiratory passages with inflammation (right).BMC Immunology 2009, 10:58 http://www.biomedcentral.com/1471-2172/10/58
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This study concentrated on two relatively easily observed
indications of lung injury not seen in every mouse--alveo-
lar dilatation (denoted by these authors as emphysema)
and hemorrhage. The results of the present study showed
the latter two findings bore no relationship to stress, aller-
gic challenge, IL-4, IL-5, the number of epithelial cells per
0.1 mm of basement membrane, or mitoses, meaning
they likely reflected injury from BAL. Although such
remodeling might be seen in mice that had not undergone
BAL as a result of an allergic insult, the changes would be
irrelevant to the determination of the presence or absence
of histologic alterations resembling asthma after BAL;
therefore we suggest studies of remodelling after BAL must
take into account the potential for BAL-induced changes.
Brewer [8] included a grading system that evaluated the
percentage of bronchioles involved. The promising results
may have been in part due to its comparing mice that
lacked an allergic/asthmatic response to mice that bore
one; among all but the four mice strains who had both
extremely low airway reactivity and inflammation, there
appeared to be no relationship between the inflammatory
scores and reactivity. The present study affirmed the diag-
nostic utility of the proportion of respiratory passages
involved by inflammation. Pastva [17] devised a semi-
quantitative inflammatory grading system that served as
the basis of the one used in this study. We did not notice
differences in cell height, which in the exercised/stressed
group shown by their figure 1b[17] appeared similar to
that seen in another published study of an unexercised
mouse group [18]. Furthermore, it was unclear what the
authors meant by degree of inflammation. Evaluation of
the modified grading system showed no results that were
inexplicable by chance, but did suggest the direction of
the remaining grading studies. Because hematoxylin and
eosin is not the best stain to evaluate mucin, any conclu-
sion with respect to mucin is of limited value.
Different mouse strains and different allergic/asthma
models yield different histological appearances [8,10-12].
For each mouse strain, a histological definition of the
murine histologic alterations resembling asthma should
be derived and verified. The current findings apply only to
the BALB/c OVA mouse model. Strain of mouse and anti-
gen/model selection will influence the inflammatory
response and persistence of airway responsiveness [11].
Varying the time between last exposure and sacrifice
decreases the acute response with time [6,31]. Molecular
markers may also be of use; Duan [14,15] evaluated the
effectiveness of p38α mitogen-activated protein kinase
anti-sense oligonucleotide and U0126, a specific MAPK/
ERK kinase inhibitor on inflammation as outcomes to
evaluate a scoring system [16]. Concerning grading
parameters, although the number of bronchial epithelial
cells/mm2 was slightly lower, consistent with the notion
that larger cells were replacing smaller cells [32,33], the
small size of the differences precludes their routine use.
Image analysis is likewise time consuming, but does have
the advantage of some objectivity. One study showed dif-
ferences in the concentration of eosinophils [18] over
time, as well as, with the use of immunohistochemistry,
changes in smooth muscle thickness [33]. When time
after stress was used as a means to provide a graded level
of mediator, the proportion of respiratory passages show-
ing inflammation and the presence of mitoses proved
important, suggesting the possibility of their utility in a
histological grading system. The histological score might
be a better guide for the severity of allergic pulmonary
inflammation than analysis of BAL fluid or chemical anal-
yses of whole tissue sample. Eisenbarth [19] assessed the
importance of differing concentrations of lipopolysach-
aride on the asthmatic response. Photographs of hema-
toxylin and eosin stained sections showed no difference
with respect to the dosage of lipopolysaccharide, notwith-
standing marked changes in the laboratory findings. In
the grading criteria proposed here, the proportion of
inflamed respiratory passages and mitoses, are of interest
because they lie in opposition to one another. One fault
of prior grading systems is the assumption that all find-
ings are additive.
The two different stresses deserve further comment. Psy-
chostimulants such as amphetamine and cocaine can
induce a withdrawal syndrome minimally obfuscated by
somatic signs, being mostly a psychological/neurochemi-
cal stressor [34]. Withdrawal from repeated amphetamine
stimulation results in distress and depressive-like behav-
iors in rodent models [34,35]. In humans, the relatively
transient withdrawal" or "distress" syndrome is character-
ized by depression, including psychomotor alterations,
dysphoria, anxiety, anhedonia and anergia [34]. Post
stimulants can also induce psychotic states in humans. In
rats, repeated administration of psychomotor stimulants,
such as amphetamine leads to behavioral sensitization
and a progressive augmentation of behavioral responses
to drug administrations, which persist even after long
withdrawal periods [34,36]. Although the forced swim
test would seem to simply be a acute physical stressor, it is
also a model of the mental stress of depression [37-39]
during acute stress, being a widely used pharmacologic
model for assessing antidepressant activity in the rodent
laboratory [35,39]. Researchers describe a "depressive"
behavior as the floating response because the swimming
behavior ceases and a state of despair or subjective help-
lessness is observed [36,38]. Neither form of stress proved
important in any overall way that could not have been
explained by chance, supporting the utility of the defini-
tion in animals that had undergone stress and animals
that had not undergone stress. Because two ampheta-
mine-stressed control animals developed a complete
response and had detectable IL-5, relationship of stress toBMC Immunology 2009, 10:58 http://www.biomedcentral.com/1471-2172/10/58
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the induction of an acute allergic response must be further
explored. Future analyses of allergic asthma might wish to
quantify differences in BAL fluid with respect to inflam-
matory mediators and extensively analyze the effects of
changes in immunization protocols to assess differences
between mice that are physically stressed and mice that
only experience psychological stress.
In another report by our laboratory, an analysis of mean
levels of IL-4, but not IL-5, were elevated among mice
exposed to the forced swim test compared to control
mice[40] Thus, while control and non-allergic-challenged
stressed mice did not differ in the proportion of mice with
detectable IL-4 in BAL, the mean levels of IL-4 were ele-
vated among stressed mice. Mice with histologic altera-
tions resembling asthma responded to stress differently
than did control mice, such that mean IL-4 levels did not
differ between stressed and non-stressed allergic ani-
mals[40] By contrast, although mean IL-5 levels were ele-
vated among allergic challenged animals, stress actually
reduced mean IL-5 levels in BAL among allergic mice[40]
Limitations of this study include the absence of image
analysis, special stains, gene expression analyses, and
immunohistochemical studies, and lack of data on airway
resistance. The definition and proposed grading system is
limited to the BALB/c OVA mouse model. Similar studies
should be undertaken for other mouse models before
identifying a histologic alterations resembling asthma.
There exists no reason a priori for levels of any specific
inflammatory mediator in any specific mouse model to
correlate with the degree of severity of an allergic chal-
lenge because inflammatory mediators may induce a
response without a proportional histological response.
The proposed grading system must be verified by a physi-
ologic grading system that includes measures of air way
resistance or pulmonary hyperresponsiveness. Despite
these limitations, the value of the histological definition
lies in the simplicity and speed with which the most com-
monly used murine model of allergic pulmonary inflam-
mation can be confirmed. With practice, the identification
of a response takes less than one minute and can be per-
formed on animals that have little or no other measures
of allergic pulmonary inflammation or asthma.
Conclusion
A definition of murine histologic changes resembling
asthma has been developed and verified. We describe and
validate histological features previously designated as
being specific to allergic pulmonary inflammation and to
the injury induced by BAL. Because the histological con-
stellation is unaffected by the presence or absence of stress
and was validated in the presence of BAL cytokine
changes, it should find utility in studies that use the BALB/
c OVA mouse model. An allergic pulmonary inflamma-
tion grading system was also proposed.
Methods
This work was approved by the Texas Tech University Ani-
mal Care and Use Committee prior to the start of work.
For the initial study, 72 female BALB/c mice (6 to 8 weeks
of age) were obtained from Charles Rivers Laboratories
(Boston, MA); two mice were housed per bedded shoebox
cage with a filter top. For the second study, 80 female
BALB/c mice (8 weeks of age) were obtained from Jackson
Laboratories (Bar Harbor, ME); two mice were housed per
bedded shoebox cage with a filter top. Differences in the
source of the animals related to purchasing arrangements
of the animal care facility, but the animal strains were
identical for all three study groups. For the third study, 25
female BALB/c mice (6 to 8 weeks of age) were obtained
from Charles Rivers Laboratories (Boston, MA); five mice
were housed per bedded shoebox cage with a filter top.
Animals were maintained at 21-23°C with a 12:12 h light-
dark cycle. Mice were provided an OVA free diet and water
ad libitum. Animal protocols were approved by the Ani-
mal Care Committee of the Texas Tech University, which
is accredited by AAALAC International. Animals were ran-
domly assigned by cage to the different treatment and
stress groups. The first study comprised six groups of
twelve mice each, randomly assigned: 1) stressed, control;
2) stressed, sensitized; 3) stressed, challenged; 4) not
stressed, control; 5) not stressed, sensitized; 6) not
stressed, challenged. The second study comprised four
groups of twenty mice each, randomly assigned: 1)
stressed, control; 2) stressed, challenged (two of whom
died); 3) not stressed, control; 4) not stressed, challenged.
For the third study, challenged, not stressed mice were
randomly assigned by cage to one of five time exposure
treatments (0, 12, 24, 36, and 48 hours).
For the first study set, stress comprised intraperitoneal
injections of amphetamine (d-amphetamine (AMP,
Sigma-Aldrich, St. Louis, MO) 1 mg/kg, dissolved in saline
less than one hour before injection)[34], on days 21, 22,
and 23; mice who did not experience stress were provided
intraperitoneal injections of sterile saline. For the second
study set, stress comprised a 20 minute forced swim in a
glass cylindrical jar, 27 cm tall, and 12 cm diameter, filled
15 cm with water maintained at 28-30°C [37]. Stress was
induced on day 26 immediately prior to euthanization for
the first two studies.
For the third study set, after the last exposure of aero-
solized 1% OVA, mice were randomly assigned by cage to
one of five time after exposure treatments (0, 12, 24, 36
and 48 h). For 0 and 12 h treatments, mice were exposed
to aerosol OVA at 7:00 h and harvested at 7:20 h and
19:20 h respectively. For 24 and 36 h treatments, mice
were exposed to aerosolized OVA at 7:30 h and harvested
the next day at 7:50 h and 19:50 h respectively. For 48 h
treatment mice were exposed to aerosol OVA at 8:00 h
and harvested 48 h later at 8:20 h. The aerosol exposureBMC Immunology 2009, 10:58 http://www.biomedcentral.com/1471-2172/10/58
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and harvest times were allotted these times due to availa-
bility of equipment, although a stringent schedule was
allotted to avoid variability from circadian effects
Immune activation was performed similarly to estab-
lished allergy models [37,41]. On days 7, 14, and 21 sen-
sitized and challenged mice received 10 μg of OVA (crude
grade IV; Sigma, St. Louis, MO) i.p. emulsified in 100 μL
of aluminum hydroxide gel (Sigma) and suspended in
100 μL of PBS [42]. Control mice received 200 μL of vehi-
cle intra-peritoneally. Systemic levels of OVA-specific
immunoglobulin (Ig)E were allowed to increase for 15
days after the fist sensitizing injection. On days 22, 23, 24,
and 25, mice allocated to the challenged treatment group
were exposed for 20 min to aerosolized OVA in PBS (1%
w/v) generated with a nebulizer (Minimate Compressor
PM, Precision Medical, Inc., North Hampton, PA) and
mice in the control and sensitized treatment groups were
exposed to aerosolized PBS for 20 min, a similar estab-
lished method to previous studies [43], immediately
before euthanization.
All mice chosen for the first two study sets were eutha-
nized on day 26 using CO2 inhalation followed by tho-
racic decompression; mice chosen for the third study set
were euthanized at time periods described above using
using CO2 inhalation followed by thoracic compression.
Immediately after euthanization, tracheas were exposed
surgically and cannulated using an 18 g needle. Lungs
were lavaged with 2 × 0.5 mL aliquots of ice cold PBS/2%
fetal bovine serum (FBS). Supernatant was collected after
centrifuging samples for 10 min at 1200 rpm and imme-
diately frozen in a -70°C freezer. Multiple analyses were
performed on the BAL fluid, blood, and serum, reported
elsewhere (Sutherland, submitted); but the only measure-
ments relevant to this effort were the IL-4 and IL-5 meas-
urements performed BAL and IgE measurements
performed on serum on the first study group when suffi-
cient material was present. IL-4 and IL-5 levels were deter-
mined by by ELISA (Assay Designs, Ann Arbor MI),
following manufacturer's guidelines, with sensitivity for
IL-4 being 4.34 pg/ml and for IL-5 being 5 pg/ml. Plasma
IgE concentrations were assayed at a 1:50 dilution by a
commercially available ELISA kit (Bethyl Laboratories,
Montgomery, TX) with a sensitivity of 3.9 ng/ml, accord-
ing to the manufacturer's instructions.
Lungs were then surgically harvested and placed into 10%
formalin for at least 5 days prior to paraffin embedding.
Histologic analyses were performed on 4 μ thick parasag-
ittal sections of whole lungs stained with hematoxylin and
eosin. Totally embedded lungs of mice were evaluated for
six changes deemed most important, as described in the
results.. Second study set lungs were further examined for
the presence or absence of alveolar dilatation and hemor-
rhage.
All mice from the first study with a complete response
were selected for evaluation of a subjective inflammatory
grading system. Pastva [17] had created a semi-quantita-
tive system to evaluate the intensity of inflammation
based on a series of subjective criteria, 1) bronchial
inflammation; 2) vascular inflammation; 3) epithelial
hyperplasia/hypertrophy; 4) goblet cells and mucin pro-
duction; and 5) overall lung appearance. Initial attempts
to distinguish overall bronchial from overall vascular
inflammation were quite difficult, and Pastva [17] found
neither a statistically significant criterion; the two criteria
were fused into "bronchovascular inflammation."
Although PAS staining was not performed, goblet cells
were identified in all mice. Some form of hypertrophy/
hyperplasia was also seen in virtually every mouse. For
these reasons, each of the three categories, 1) bronchovas-
cular inflammation, 2) epithelial hyperplasia/hypertro-
phy, and 3) goblet cell metaplasia/mucin production, was
graded on a 1-4 scale, with 4 being the most severe and 1
being the least. Scores were multiplied by an overall sever-
ity score, graded from 1-4, and summed to yield an
inflammation index. From the second study set were cho-
sen 32 challenged mice with a complete histologic
response and 32 control mice, none of whom had had a
complete histologic response, for quantitative evaluation
of two proliferation/hypertrophy indices: for each mouse
the largest non-tracheal airway was evaluated at 200× for
1) the presence or absence of bronchial epithelial mitoses
and 2) the number of epithelial cells counted over 0.1 mm
of basement membrane in a flattened area. All mice in the
third study set with a complete response were evaluated
for two parameters: 1) the largest two non-tracheal air-
ways were evaluated at 200× for the presence or absence
of mitoses; 2) for all material on the slide, non-tracheal
respiratory passages were evaluated at 100× for chronic
inflammatory infiltrates and the number with and the
number without inflammatory infiltrates were recorded.
Fisher's exact tests, two-tailed, evaluated contingency
tables, with exact methods used to establish 95% confi-
dence intervals (95% c.i.) for 2 × 2 tables. A Kruskal-Wallis
tests, two-tailed, evaluated differences in medians. For
univariate comparisons with a continuous outcome varia-
ble, simple linear regression analyses calculated point esti-
mates and 95% c.i. of mean differences. For multivariate
comparisons with a continuous outcome variable, log
gamma regression calculated point estimates and 95% c.i.
of mean ratios for continuous outcome variables. Bino-
mial logistic regression analyses calculated adjusted odds
ratios (OR) and 95% c.i. for multivariate analyses with
dichotomous outcome variables and with analyses of
dichotomous outcome variables with continuous predic-
tor variables. Multinomial logit regression analyses calcu-
lated relative risks (RR) and 95% c.i. for categorical
outcome variables other than dichotomous. Null hypoth-
eses were rejected when P < 0.05.BMC Immunology 2009, 10:58 http://www.biomedcentral.com/1471-2172/10/58
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